Pharmacogenomics study shows link between testing and better health outcomes

By Kate McCaffery | Sept. 24, 2020, 9:37 a.m.

Photo: Freepik

“The question we were trying to answer was if clinicians are provided access to pharmacogenomic test results during routine clinical care, would patient outcomes improve?”

This article is reserved to PRO Level subscribers

Discover the PRO Level

The most popular in Health

Voluntary group critical illness insurance makes a breakthrough

Regulator suspends more than one hundred Ontario health service providers

Insurers sticklers for snowbirds' health stability

Headlines

Mercer compensation survey examines inflation pressures

The big reasons to take care of the little things in your business

Flood Insurance: Solution expected by late 2022

Related topics …

GREEN SHIELD CANADA

Telemedicine: Provider-insurer partnerships multiplying

Beneva supports gender transition in group insurance

Disability claims due to mental health issues on the rise

Green Shield seeking to become the main care provider in Canada

HBM+

Green Shield study confirms benefits of pharmacogenomic testing

Green Shield harnesses artificial intelligence to detect and prevent benefits fraud

Medication

Study indicates a significant gap in access to care for chronically ill

Actuaries’ association publishes updated mortality tables

Drug plan claim averages jump nearly nine per cent in 2021

TD Bank to help Canadians dealing with cancer

Magazine supplement

Voluntary group critical illness insurance makes a breakthrough

Inflation continues to fuel travel insurance concerns

Insurers sticklers for snowbirds' health stability

Individual critical illness insurance: The main products available in Canada

Pharmacogenomics study shows link between testing and better health outcomes

Choose your payment method

Confirmation